Harry Lam, PhD Sanofi

Dr. Harry Lam is currently VP, Head of Biologics Manufacturing, at Sanofi. Most recently, he was VP, Manufacturing and Technical Operations, at Progenitor Cell Therapy, A Caladrius Biosciences Company. Dr. Lam has over 30 years of experience in biopharmaceutical manufacturing, including 17 years at Genentech, where he held a variety of positions with increasing responsibilities, including Director of Manufacturing & Technology, Genentech Singapore Pte Ltd; Senior Director, Global Biologics Drug Substance Manufacturing Science & Technology; and ultimately Roche Global Head of Contract Manufacturing Operations, Commercial Drug Substance. Prior to joining Genentech, Dr. Lam spent 11 years at Pfizer in the Bioprocess R&D department. He received his Ph.D. in Chemical Engineering from Rensselaer Polytechnic Institute and his B.Sc. in Chemical Engineering from the University of Birmingham, UK.